• Home
  • Articles
  • Cut zetia in half, Cut Zetia sales estimates in half.

Cut zetia in half, Cut Zetia sales estimates in half.

Author :

Tags: mrk, sgp, vytorin, zetia

More bad news for MRK and SGP. A presentation which hadn't gathered any pre-meeting publicity shows that cutting zetia in half can half costs, while not altering affect on lipids.

  Comments: 0

Another abstract from the AHA (3728, by Baruch et al. ) which will be released at the meeting this week shows that 5mg of Zetia is just as effective as 10mg of zetia either alone or when combined with a statin. The presentation suggests that cutting zetia in half( or presumably prescribing higher dose vytorin and then cutting it in half) could save our healthcare system a lot of money. They reported that by making 5mg the mandatory starting dose at their institution, they saved $40,000 at their hospital alone.

In this era of healthcare cost control, this is an easy change with no downside. I would expect this data to over time reduce sales of zetia and vytorin. Don’t expect MRK or SGP to talk about these results, but the data will filter out.

Find the best Savings or CD Rate

Advertiser Disclaimer. Some of the savings offers appearing on this site are from advertisers from which this website receives compensation for being listed here. This compensation may impact how and where products appear on this site (including, for example, the order in which they appear).

Financial products of all nature bear inherent risks and this website is not a financial advisory service. BestCashCow.com provides information related to rates on US-based savings accounts, CD (certificate of deposit) rates, money market accounts, money market funds, government bonds, other bonds and income producing securities, commodities, equity securities, mortgage rates, home equity rates and auto loans rates, free of charge to internet users for their independent use. The accuracy of information on the website is not guaranteed, and no financial product of any sort is endorsed. On certain web pages, BestCashCow.com may contain discussion and analysis of the risks and rewards associated with certain financial instruments, including equity instruments, or may link to other pages with such discussions. The information should not be construed to provide investment advice. In fact, users are specifically warned against following any advice related to specific instruments, including advice that may be on other web pages linked from BestCashCow.com. Please seek personalized advice on the risks and applicability to your own circumstances of any financial product from a qualified professional. © BestCashCow.com, LLC, 2014.